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ABSTRACT
Weibel-Palade bodies (WPBs) are endothelial storage organelles that
mediate the release of molecules involved in thrombosis,
inflammation and angiogenesis, including the pro-thrombotic
glycoprotein von Willebrand factor (VWF). Although many protein
components required for WPB formation and function have been
identified, the role of lipids is almost unknown. We examined two
key phosphatidylinositol kinases that control phosphatidylinositol
4-phosphate levels at the trans-Golgi network, the site of WPB
biogenesis. RNA interference of the type II phosphatidylinositol
4-kinases PI4KIIα and PI4KIIβ in primary human endothelial cells
leads to formation of an increased proportion of short WPB with
perturbed packing of VWF, as exemplified by increased exposure of
antibody-binding sites. When stimulated with histamine, these cells
release normal levels of VWF yet, under flow, form very few platelet-
catching VWF strings. In PI4KIIα-deficient mice, immuno-microscopy
revealed that VWF packaging is also perturbed and these mice
exhibit increased blood loss after tail cut compared to controls. This is
the first demonstration that lipid kinases can control the biosynthesis
of VWF and the formation of WPBs that are capable of full
haemostatic function.
KEY WORDS: Phosphatidylinositol 4-kinase alpha,
Phosphatidylinositol 4-kinase beta, Weibel-Palade body,
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INTRODUCTION
Endothelial cells line the inner layer of all blood vessels and play a
crucial part in regulating vessel formation, function and structure.
They are adaptable cells that can quickly respond to stimuli in the
blood or tissue to control vessel tone, haemostasis and immune
responses. Endothelial cells are characterised by the presence of
large rod-shaped secretory organelles called Weibel-Palade bodies
(WPBs), which store a variety of factors essential to their function
that can be quickly released into the vessel lumen in response to
stimuli. The primary cargo of WPBs is von Willebrand factor
(VWF), a highly multimerised glycoprotein. Exocytosis of WPB
cargo results in unfurling of VWF tubules into long strings,
exposing platelet-binding sites and serving to tether platelets to sites
of vascular injury, a fundamental step in primary haemostasis. In
vonWillebrand disease, mutations in VWF can perturb formation of
WPBs and affect the release of VWF and the string formation,
leading to excessive bleeding (Michaux et al., 2003; Sadler, 1998;
Valentijn and Eikenboom, 2013), thus correct biogenesis of WPBs
and storage of VWF is crucial for normal haemostasis.
A key phase in establishing a fully functional WPB is its initial
formation at the trans-Golgi network (TGN), where the lumenal
milieu supports the commencement of VWF multimerisation, pro-
protein cleavage and tubulation within the TGN lumen (Sadler,
2009). These processes are essential to the recruitment of otherWPB
cargo – such as P-selectin, which binds to correctly folded VWF
(Lui-Roberts et al., 2005), and the cytoplasmic machinery, such as
the clathrin adaptor protein 1 (AP-1) and clathrin itself, which are
required for early WPB formation (Lui-Roberts et al., 2005). Less
well-understood proteins such as aftiphilin and γ-synergin are also
involved, and affect the secretory pathway taken by WPBs (Lui-
Roberts et al., 2008). Other proteins essential to later stages of the
formation, maturation, transport and exocytosis of WPBs are still
being identified (Nightingale and Cutler, 2013), and a highly
complex process involving multiple protein complexes at different
stages of the life-cycle of this organelle is now being revealed.
In contrast to this rapidly expanding set of protein machinery, the
contribution of lipids to WPB formation and function is poorly
understood. Phosphoinositides (PIs) are minor components of
eukaryotic cell membranes – yet essential to the regulation of
diverse cellular processes, including signal transduction, vesicle
trafficking, cytoskeletal organisation and platelet function (Liu and
Bankaitis, 2010; Min and Abrams, 2013). Through their restricted
membrane distribution PIs can act as the lipid determinants of
membrane identity, supporting localised recruitment of proteins
through coincidence detection (Behnia and Munro, 2005; Carlton
and Cullen, 2005). At the TGN, PI 4-phosphate (PI4P) is the
predominant PI (Balla and Balla, 2006) and has been shown,
together with the ADP-ribosylation factor Arf-1, to recruit AP-1,
thereby facilitating formation of clathrin-coated vesicles and
exocytic carriers (D’Angelo et al., 2007; Demmel et al., 2008;
Duncan and Payne, 2003; Hanada et al., 2007; Levine and Munro,
2002; Mills et al., 2003; Wang et al., 2007, 2003). Generation of
PI4P at the TGN in mammals is regulated primarily by the type II
PI4-kinases PI4KIIα and PI4KIIβ (Balla and Balla, 2006). Studies
in various mammalian cell lines have shown a role for either
PI4KIIα (Wang et al., 2003) or PI4KIIβ (Craige et al., 2008;Wieffer
et al., 2013) in mediating AP-1 recruitment to the TGN. The singleReceived 10 February 2016; Accepted 4 April 2016
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PI4KII enzyme in Drosophila has been shown to be required for
trafficking of secretory granule proteins (Burgess et al., 2012),
although not through regulation of AP-1 recruitment to the TGN.
Whether either of the type II PI4Ks has a similar function in
mammals is unknown, although our previous studies suggest that a
role in WPB formation and function is likely. Our investigations
reveal a crucial role for these kinases, in supporting the formation of
WPBs, the ability of endothelial cells to produce pro-thrombotic
VWF strings and to provide a fully functional haemostatic system in
mice.
RESULTS
A TGN-located pool of PI4P can be detected in HUVECs
To confirm the presence of a TGN-located pool of PI4P in human
endothelial cells, we overexpressed a GFP-tagged version of the
specific PI4P sensor protein SidC (GFP-SidC) (Luo et al., 2015) in
human umbilical vein endothelial cells (HUVECs). The PI4P sensor
primarily decorates a typical Golgi structure – overlapping with the
TGN marker TGN46 – but not the adjacent WPBs (Fig. 1A),
indicating high levels of the lipid at the TGN where WPBs are
formed, but not on mature WPBs. The expression of the kinases
PI4KIIα and PI4KIIβ in HUVECs was confirmed by western
blotting (Fig. 1B) and quantitative real-time (qRT)-PCR (Fig. 1C),
and each kinase can be specifically ablated by small interfering
RNA (siRNA) (Fig. 1B,C).
RNAi-meditated ablation of PI4KIIα and/or PI4KIIβ produces
shorter WPBs with abnormally folded VWF
The elongated cigar-like shape of WPBs reflects the presence of
VWF correctly folded into the tubules that are crucial to its function
(Michaux et al., 2003). We have previously shown that interference
with the protein machinery involved in early WPB formation at the
TGN can alter their shape (Michaux et al., 2006a). We now find that
confocal microscopy also suggests a change in the morphology of
WPBs in PI4KIIα and/or PI4KIIβ depleted HUVECs. To confirm
this, an unbiased automated high-throughput morphometric
analysis was performed (Ferraro et al., 2014), where >105 WPBs
were analysed per condition (a detailed explanation of the rationale
behind the presentation of this data can be found in Fig. S1). We find
that the distribution of WPB length (Feret diameter) was
significantly altered in all PI4KII kinase-depleted samples,
showing an increase in the proportion of short relative to long
VWF-positive objects (Fig. 2A). This was mirrored by a change in
length when WPBs deficient in PI4KIIα were analysed by using
electron microscopy (EM) (Fig. S2).
Whereas longer WPBs represent a minority of the total WPB
population, they contain a disproportionally large amount of VWF
(Ferraro et al., 2014) (Fig. S1) and also produce the largest and,
thus most active VWF structures on release (Ferraro et al., 2014).
We, therefore, examined the effects of loss of the PI4KII kinases
specifically on the population of longer WPB, which corresponds
to 50% of the total VWF area. We find that there are significantly
fewer long WPBs when PI4KIIβ is ablated compared to the effect
of suppressing PI4KIIα (Fig. 2B), and that loss of both kinases
gives a greater effect than ablation of either alone, together giving
a 55% decrease in the number of long WPBs. This suggests that
PI4KIIα and PI4KIIβ are both important for early WPB formation
and their combined effect is, at least, additive. We predicted that
this dramatic decrease in the proportion of long WPBs can have
deleterious effects on WPB function, on the basis of our previous
findings that a 50% decrease in the number of long WPBs causes a
catastrophic decrease in the number of VWF strings generated by
endothelial cells (Ferraro et al., 2014). We, therefore, proceeded to
investigate whether this is, indeed, the case.
WPB shape depends to a large extent on the correct folding of
VWF into proteinaceous tubules (Michaux et al., 2006a), so if
depletion of the PI4KII isozymes causes a change in WPB shape,
it is possible that the structure of VWF is altered within these
PI4KII-deficient cells. Previously, we have observed that,
following treatment with monensin, deliberate unfolding of
VWF within WPBs causes a loss of propeptide binding and the
consequent unfolding of intraorganellar VWF. This not only
leads to their change from cigar-shaped to spherical organelles
(Michaux et al., 2006a) but also increases the intensity of VWF
staining in immunofluorescence analyses (Gregory Michaux and
D.F.C., unpublished observation), presumably due to a higher
accessibility of epitopes to the VWF antibody. If the defect in
WPB shape, as seen in the PI4KII-depleted cells, partly reflects a
Fig. 1. Localisation of PI4P, and RNAi
of PI4K2A and PI4K2B in endothelial
cells. (A) Representative confocal image
of a HUVEC transfected with the PI4P
probe GFP-SidC, fixed, permeabilised
and labelled with DAPI nuclear stain
(blue), anti-TGN46 (red), anti-GFP
(green) and anti-VWF (cyan). Scale bar:
10 µm. HUVEC were transfected with
vehicle (Mock), or siRNAagainst PI4K2A,
PI4K2B or both PI4K2A and PI4K2B
(PI4K2A&B). (B,C) The efficiency of
knockdown was assayed by detecting
protein levels (western blotting, B) or
mRNA transcript levels (qRT-PCR; C).
Means±s.e.m. of six experiments are
shown in C.
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failure to correctly pack VWF into WPBs, we hypothesise that
WPBs in these cells display brighter VWF fluorescence intensity
than WPBs in control cells. Moreover, monensin treatment
should produce a significant decrease in the length of control
WPBs as well as an increase in the staining intensity of VWF,
but the magnitude of these effects should be less in PI4KII-
deficient cells. Indeed, we found that WPBs in PI4KII-depleted
cells are significantly brighter than WPBs in mock-treated cells
(Fig. 2C–E), as shown by the shift of the frequency distribution
towards a higher intensity. Images of these WPBs in HUVECs
treated with vehicle or monesin are shown in Fig. 3, illustrating
that – in monensin-treated cells – VWF-positive objects become
smaller (Fig. 3A,B). Interestingly, the difference between the
frequency distributions with and without monensin treatment is
less in the PI4KII-depleted cells than in controls, as indicated by
a decrease in the value for the Kullback–Leibler distance (KLD)
(Fig. 3B). The dramatic effect of monensin on WPB length is
exemplified by a significant decrease in the proportion of long
(>2.35 μm) VWF-positive objects in all groups (Fig. 3Ci).
Again, the magnitude of this shift is smaller in PI4KII-depleted
cells (Fig. 3Cii). Taken together, these results point towards a
defect in packing of VWF within WPBs in PI4KII-depleted cells.
PI4KIIα-deficient mice display abnormal WPBs
We have previously generated a gene-trapped mouse strain
lacking PI4KIIα activity (Simons et al., 2009). These mice
initially appear normal but develop late-onset spinocerebellar
degeneration. To extend our in vitro observations we examined
WPBs in the neuroretinal vasculature of these mice, as there is no
known viable mouse model for PI4KIIβ deficiency. The retina is
a readily accessible tissue that can be mounted as a flattened
preparation, allowing some limited light-microscopic analyses of
WPBs in a physiological context. Confocal imaging revealed the
presence of a high number of WPBs within vessels of the
superficial plexus and their alignment with the direction of flow
in the superficial arterioles was clearly apparent (Fig. 4A). This
is in contrast to reports on HUVECs grown under flow
conditions, where no relation between the direction of flow and
the orientation of the organelles was observed (Dragt et al.,
2012). The parallel alignment of the WPBs should facilitate
Fig. 2. Morphometric analysis of VWF-
positive structures in PI4KII-depleted cells.
(A–C) The morphology of WPBs in HUVECs
transfected with vehicle (Mock) or siRNA
against PI4K2A, PI4K2B or both PI4K2A and
PI4K2B (PI4K2A&B), was analysed by using an
unbiased high-throughput method. The Feret
diameter (A, B) and maximum fluorescence
intensity (C-E) of VWF-positive objects in
confocal images of HUVECs labelled with anti-
VWF was measured. Graphs are representative
of at least three determinations. In A, a
cumulative frequency distribution representative
of three determinations is shown. In each case,
the results for the siRNA-treated groups were
considered significant by Wilcoxon rank-sum
test (P<0.0001). In B, the percentage of VWF-
positive objects with a Feret diameter of
>2.35 µm is shown (see Fig. S1). Means±s.e.m.
of eight replicate wells, analysed by one-way
ANOVAwith Dunnett’smultiple comparison test,
compared to the mock sample. ns, non-
significant; ***P<0.001. In C–E, frequency
distributions of the maximum intensity values for
each VWF-positive object are shown. Data were
analysed by using the Wilcoxon rank-sum
test. A. U, arbitrary units.
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measurement of WPB Feret diameter from confocal images;
however, we could not detect a change in WPB length within the
retinal vasculature of PI4KIIα-deficient mice (data not shown).
In contrast, when we examined the fluorescence intensity of the
VWF-positive objects, we detected a significant increase in
intensity in the endothelial cells of the PI4KIIα-deficient mice
compared with littermate controls (Fig. 4B) that is mirrored by
our in vitro data. Interestingly, there were more VWF-positive
objects per unit area in the PI4KIIα-deficient mice compared to
that of controls (Fig. 4C), which is different to our in vitro
observations (data not shown).
PI4KII-deficient HUVECs secrete normal levels of correctly
multimerised VWF, but string formation is impaired and
PI4KIIα-deficient mice exhibit a bleeding phenotype
VWF function in haemostasis depends not only on the amount
released but also on its structure (Nightingale et al., 2009). Despite
the clear effects of PI4KII-deficiency on WPB morphology and
folding of their VWF content, no quantitative defect in VWF
secretion was found, which is consistent with previous results
(Michaux et al., 2006a). RNA interference (RNAi)-mediated
ablation of either or both kinases did not alter the amount of VWF
released from unstimulated HUVECs (Fig. 5A). Moreover, the
Fig. 3. Examination of VWF-positive objects after treatment with monensin. HUVECs were transfected with vehicle (Mock) or siRNA against PI4K2A,
PI4K2B or both transcripts, and treated with vehicle or monensin. (A) Opera acquired confocal sections showing VWF immunolabelling. Scale bar: 20 µm.
(B) Cumulative frequency distributions of the Feret diameter of VWF-positive structures in cells treated with vehicle (line) or monensin (dotted line), together with
results of Wilcoxon rank-sum test (P value) and Kulback–Leibler distance (KLD). Representative of three determinations. (C) Data from B displayed as a
percentage of VWF-positive objects with a Feret diameter >2.35 µm (Ci) or the difference in mean Feret diameter between vehicle andmonensin-treated samples
(Cii). Means±95% confidence interval of eight replicate wells are shown. Data shown in Cii were analysed using one-way ANOVA with Dunnett’s multiple
comparison test compared to the mock sample. ns, non-significant; **P<0.01, ***P<0.001.
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levels of VWF secreted in response to the protein kinase C
activator phorbol 12-myristate 13-acetate (PMA) (Fig. 5B) or the
physiological agonist histamine (Fig. 5C) were comparable to
control HUVECs, and total VWF content was largely unchanged
(Fig. 5D).
VWF multimers of higher molecular weight adhere better to
collagen and platelets (Federici et al., 1989) and are, thus, more
effective at supporting thrombus formation in conditions of high
shear stress. We next examined the multimeric state of VWF
secreted from PI4KII-deficient HUVECs and, again, detected no
differences between control and kinase-deficient samples
(Fig. 5E), suggesting that the ability of VWF to multimerise
remains unaffected in these PI4KII-deficient cells. However,
because an important role of WPBs during haemostasis is the
production of long VWF-strings on the surface of endothelial cells
for platelet capture (Michaux et al., 2006a; Valentijn and
Eikenboom, 2013) and because short WPB can give altered
string production without affecting VWF multimerisation (Ferraro
et al., 2014), we postulated that the effect of the alterations in
VWF structure that is reflected in the changes in WPB shape
becomes apparent when partially misfolded VWF filaments unfurl
and combine during string formation. We, therefore, examined the
ability of PI4KII-deficient HUVECs to produce and release VWF
strings.
Mock and siRNA-treated HUVEC were placed under flow,
treated with histamine to stimulate WPB exocytosis and then fixed
under flow to maintain the integrity of the VWF strings produced.
Cells were then surface stained with anti-VWF and processed for
image acquisition (Fig. 6A). A dramatic reduction in the mean
number of VWF strings, of 60% (±7%) for PI4KIIα and 56%
(±12%) for PI4KIIβ, when compared to controls was observed
(Fig. 6B). Ablation of both enzymes together is significantly more
effective than either kinase alone, reducing VWF string number by
84% (±16%). Of note, the mean length of the few VWF strings
measured in all of the siRNA-treated cells was similar (Fig. 6C)
which, combined with the reduction in string number, is a
previously unknown phenotype. Together, these results suggest
that these closely related kinases have overlapping but non-
redundant functions in WPB biogenesis and VWF string formation.
Finally, we investigated the possibility that the degree of string
loss observed in vitro is accompanied by a phenotype of excessive
bleeding in vivo. To investigate the effect of PI4KII-deficiency on
haemostasis, blood loss volume in Pi4k2aGT/GT and control mice
was measured after amputating the tail tip of the mice (Fig. 6D).
Two cohorts of mice, totalling ten mice per group, were
independently analysed. In each case, the volume of blood lost
after 7 min was significantly greater in PI4KIIα-deficient mice,
suggesting altered haemostasis in the absence of PI4KIIα.
DISCUSSION
WPB biogenesis and the structural processing of VWF are
interdependent processes that underpin the availability and
function of WPB cargo, which can be physiologically modulated
or affected by disease. The data presented here establish a regulatory
role for two lipid kinases, PI4KIIα and PI4KIIβ, in these processes.
We propose that production of PI4P at the TGN through these
isozymes can orchestrate the recruitment of proteins and lipids
involved in WPB formation. Ablating the expression of PI4KIIα
and PI4KIIβ in primary endothelial cells results in a so-far-unknown
and complex phenotype; a change inWPBmorphology and internal
VWF structure and, despite normal levels of VWF secretion, a
massively reduced number of VWF strings released under flow
upon endothelial activation. In addition, mice deficient in PI4KIIα,
have abnormal WPBs and impaired haemostasis, which mirrors and
extends our in vitro data.
The deliberate reduction of VWF expression can produce fewer
and shorter WPBs (Ferraro et al., 2014). However, in this case
siRNA-mediated ablation of PI4KIIα and PI4KIIβ does not affect
the total amount of VWF within cells or secreted by cells, and the
WPB number per cell is not altered in vitro. Yet, when we
examined the shape of these WPB by using an unbiased high-
throughput automated method, we discovered that, generally,
WPBs were significantly shorter. This was most apparent when
the functionally more significant ‘long’WPBs were examined; we
observed a 60% loss of WPBs longer than 2.35 μm when both
isozymes were ablated. Although we could not reliably measure
WPB length in vivo, we did observe a greater density of WPBs in
the neuroretinal endothelium of PI4KIIα-deficient mice compared
with those of littermate controls, implying an alternative
regulation of the relationship between number and size of
WPBs. Whether this reflects a difference between the in vitro
and in situ situation of species or of tissues is unclear. However,
given the complexities that our detailed analyses are revealing,
such differences are not surprising.
Fig. 4. Confocal analysis of WPBs in the retinal vasculature of PI4KIIα-
deficient mice. (A) Representative maximum intensity projections of retinal
blood vessels from wild-type or Pi4k2aGT/GT mice, showing VWF
immunolabelling. Scale bars: 10 µm or 2 µm (insert). (B) Cumulative frequency
distribution of the maximum intensity of VWF-positive objects in similar images
from wild-type or Pi4k2aGT/GT mice, analysed by Mann–Whitney test. (C) The
number of VWF-positive objects per unit area analysed by unpaired t-test.
**P<0.01. A.U., arbitrary units.
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We have previously shown that treatment of HUVECs with
monensin or chloroquine, to neutralise the pH of acidic organelles,
causes a loss of VWF tubules and shortening of WPBs (Michaux
et al., 2006a). We hypothesised that, if VWF tubulation is affected
in PI4KII-depleted cells, monensin should have a reduced effect on
the WPB of PI4KII-depleted cells compared to controls. Our
unbiased high-throughput approach confirmed this. Moreover, in
cells where PI4KIIα and PI4KIIβ are both ablated and WPBs are
severely abnormal, monensin still shortens the WPBs, suggesting
some retention of tubular coiling. It is notable that these WPBs –
like monensin- or chloroquine-treated WPBs (Michaux et al.,
2006a) – respond normally to secretagogue stimulation. Together,
these data strongly suggest that the loss of PI4KIIα or PI4KIIβ
affects the intra-organellar milieu of the WPB, impacting on VWF
string structure.
Further analysis showed that WPBs in PI4KII-deficient HUVECs
also show an increase in VWF antibody binding. This change was
significant in both the PI4KIIα- and PI4KIIβ-ablated cells but each
phenotype was, again, exacerbated when both kinases were
suppressed. We propose that the relative intensity of VWF
staining can be used to measure tubule integrity or packing within
WPBs, and that the VWF in WPBs of PI4KII-deficient HUVECs is
not as tightly-packed as in controls (Geysen et al., 1987).
Importantly, the data obtained by using intensity measurements
from PI4KIIα-deficient mice are in agreement with the in vitro data
and further demonstrate that WPBs are abnormal in these mice.
Moreover, the phenotype of excessive bleeding observed in these
mice is consistent with this defect in WPB formation.
The general technique to investigate WPB defects is the enzyme-
linked immunosorbent assay (ELISA) for the detection of VWF
release, which can be used as a reporter of both defective WPB
formation and of exocytic failure. In this study, we did not see any
secretory phenotype in the siRNA-treated cells when carrying out
VWF ELISA. However, the production of extruded VWF strings is
affected by several other factors, including the length of WPBs
(Ferraro et al., 2014) and VWF tubulation (Michaux et al., 2006a).
Both of these factors are affected here, and analysis under flow
revealed a dramatic fall in the number of VWF strings in the
PI4KII-depleted cells, with the double knockdown cells, again,
showing the biggest change. Shorter WPBs generated by
fragmenting the Golgi complex can cause shorter strings to be
formed (Ferraro et al., 2014); however, here, shorter WPBs are not
Fig. 5. Effect of PI4KII-kinase depletion on secreted
VWF protein. (A–C) HUVECs treated with vehicle
(Mock) or siRNA against PI4K2A, PI4K2B or both
transcripts were either not stimulated (A), stimulated
with PMA (B) or with histamine (C). Secreted VWF
(A–C) and total VWF levels (D) were measured by
ELISA and were typically 3% (±0.6%) (unstimulated),
10% (±1.2%) (histamine) and 24% (±2.9%) (PMA) of
total VWF content. Here secreted VWF is presented as
a percentage of mock values. Means±s.e.m. of three to
six experiments are shown and were not significantly
different (analysed using one-way ANOVA).
(E) Secreted VWF from unstimulated (60 min) or
histamine-stimulated (30 min) HUVECs was analysed
for VWF multimer distribution on a non-reducing
multimer gel. No differences were observed between
samples.
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associated with shorter VWF strings but, rather, with a decrease in
string number. The magnitude of this decrease in the double
knockdown suggests that in a 100% efficient treatment with siRNA
there may be no strings formed at all. Thus, a different and,
potentially, unknown mechanism is likely to be in play and
warrants further investigation.
PI4KIIα is reported to be the prominent regulator of PI4P
formation at the TGN and is constitutively resident at the TGN and
endosomal boundary (Simons et al., 2009; Wang et al., 2003).
PI4KIIα can associate with adaptor proteins AP-1 (Wang et al.,
2003) and AP-3 (Craige et al., 2008), and with Hermansky–Pudlak
syndrome protein complexes (Salazar et al., 2009), and is important
for regulation of receptor tyrosine kinase (Minogue et al., 2006) and
Wnt signalling (Mossinger et al., 2012; Pan et al., 2008; Qin et al.,
2009). Less is known about its close relative PI4KIIβ, a partially
cytosolic enzyme that is believed to associate with membranes in
response to stimuli such as growth factor (Wei et al., 2002), and
which may associate with clathrin coated vesicles (Li et al., 2012).
How the loss of these enzymes causes the alterations inWPB length
and VWF folding or packing is still unclear, but the fact that kinase
ablation does not affect the amount of VWF produced or secreted
suggests that their primary affects are at the TGN, modulating initial
WPB formation. Since HPS6, a subunit of the BLOC-2 complex, is
needed for VWF exocytosis from HUVECs (Sharda et al., 2015),
and the related BLOC-1 complex binds to PI4KIIa in association
with AP-3 (Salazar et al., 2009) in a complex that also associates
with BLOC2, we cannot rule out other explanations, such as a more
indirect effect involving this endosome-associated complex.
One possibility is that loss of type II PI4Ks reduces recruitment of
AP-1 to the TGN. To our surprise, we did not see an AP-1-
deficiency phenotype, i.e. formation of small VWF-positive
punctae and loss of regulated secretion (Lui-Roberts et al., 2005).
However, PI4P has been reported to induce curvature in model
membranes at physiologically relevant concentrations (Furse et al.,
2012) and can regulate the recruitment of other PI4P-binding
proteins, including the Golgi-localising, gamma-adaptin ear-
domain homology, ARF-binding (GGA) adaptor proteins (Wang
et al., 2007) and lipid-transfer proteins that include oxysterol-
binding protein (OSBP), ceramide transfer (CERT) and four-
phosphate-adaptor (FAPP) proteins (Banerji et al., 2010; Hanada
et al., 2003; Liu et al., 2014), which facilitate changes in membrane
composition and shape through curvature-inducing domains (e.g.
epsin N-terminal homology domains) and by directing coat
assembly, or by generating membrane asymmetry (Natarajan
et al., 2009). Identifying which of these downstream players are
important to WPB formation is part of our future studies.
We present new tools to detect and analyse defects in WPB
biogenesis and VWF structure, for example, the use of monensin and
antibody accessibility to unravel VWF folding or packing. Unbiased
high-throughput automated analysis enables quantification of large
numbers of WPBs and reveals morphological differences that,
otherwise, might well be missed.
Fig. 6. Effect of PI4KII-kinase depletion on VWF
string formation in vitro and bleeding time in vivo.
(A) HUVECs treated with vehicle (Mock) or siRNA
against PI4K2A, PI4K2B or both transcripts
(PI4K2A&B) were stimulated with histamine under flow
to release VWF strings, then fixed under flow and their
surface was labelled with anti-VWF for imaging. Scale
bar: 50μm. (B,C) String number per cell (B) and string
length (C), were then measured, with whisker plot
showing mean, maximum and minimum of more than
four experiments. Data were analysed by one-way
ANOVA (P<0.0001) and Tukey’s multiple comparison
post-test employed to compare all samples to mock
(***P<0.001), or between siRNA-treated groups as
indicated (not significant (ns), #P<0.05, ##P<0.01).
(D) Blood loss volume following tail cut from
Pi4k2aGT/GT mice from two cohorts of five mice per
condition was measured. Each dot represents a single
mouse. Lines represent the mean from each
independent cohort. Data were analysed by Wilcoxon
rank-sum test. **P<0.05. Removal of outliers (bleeding
time >1200 s) from the analysis resulted in **P<0.01.
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Together, this first demonstration of PI kinases being important
for the formation and function of a regulated secretory organelle in
mammals highlights the importance of lipid-modifying enzymes as
cellular controls on WPB formation. We suspect that this is only the
first report of analyses that might ultimately reveal the role of
different kinases in controlling a number of different steps that
underpin VWF function.
MATERIALS AND METHODS
Antibodies
Rabbit polyclonal anti-VWF used for ELISA (dilution 1:600), multimer gel
(dilution 1:4000) and extracellular string analysis (dilution 1:10,000) was
from DakoCytomation. VWF-HRP-conjugated antibody used for ELISA
(1:1000) was from DakoCytomation. Sheep polyclonal anti-VWF (dilution
1:1000) and anti-TGN46 (dilution 1:500) used for Immunofluorescencewere
from Serotec. For high-throughput morphological analysis, a rabbit antibody
targeting the pro-region of VWF was used (dilution 1:1000) (Hewlett et al.,
2011). Alexa-Fluor(-488, -594 or -647)-conjugated secondary antibodies (all
used at 1:500 dilution) were from Life Technologies. Anti-PI4KIIα and anti-
PI4KIIβ antibodies for western blotting (dilutions 1:2000 and 1:250
respectively) have been previously described (Mossinger et al., 2012).
Anti-β-actin was from Santa Cruz (dilution 1:500). Rabbit and mouse HRP-
conjugated secondary antibodies were from Jackson ImmunoResearch
Laboratories (dilutions 1:500 and 1:3000, respectively).
Tissue culture and transfection
HUVECs were cultured and transfected as described previously (Michaux
et al., 2006b). To minimise effector-binding inhibition artifacts the GFP-
SidC construct (Luo et al., 2015) was expressed for just 20 h and only
medium- to low-expressing cells were analysed. For monensin treatment,
HUVECs were incubated with 10 μM monensin for 1 h at 37°C just before
processing for immunofluorescence.
RNAi and nucleofection
PI4KIIα and PI4KIIβ depletion was achieved by using siRNAs with the
sequence 5′-GGAUCAUUGCUGUCUUCAA(TT)-3′ and 5′-GGUUCA-
AGUGGAAGUUACU(TT)-3′ (Eurofins/MWG), respectively. Mock
transfections were performed in parallel without siRNA. HUVECs
underwent two rounds of transfection with 300 pmol of siRNA per nucle-
ofection (Amaxa Biosystems) as described previously (Lui-Roberts et al.,
2008). Cells were assayed 2 days following the second round of
nucleofection at 100% confluency.
Real-time qPCR
At the end of each experiment HUVECs were collected for RNA extraction,
cDNA preparation and quantitative real-time (qRT)-PCR as previously
described (Nightingale et al., 2009). Gene expression was quantified by the
2−ΔΔC(T) method (Livak and Schmittgen, 2001) normalised with a β-actin
internal control. The primers used for β-actin amplification were 5′-TGG-
TGGTGAAGCTGTAGCC-3′ and 5′-GCGAGAAGATGACCCAGAT-3′.
For PI4K2A, the primers 5′-ATTGCCTCGATCAGTGTTGC-3′ and
5′-ACCAAAGGTTGGTTCATTCC-3′ were used. For PI4K2B, a Qiagen
QuantiTect primer assay (catalogue number QT00059549) was used.
VWF secretion assays
The VWF secretion assay has been described previously (Lui-Roberts et al.,
2005). In short, cells were rinsed and incubated in serum-free medium for
30 min for collection of unstimulated secretion. The medium was then
collected and replaced with fresh medium containing secretagogues, either
100 ng/ml phorbol 12-myristate 13-acetate (PMA) or 10 μM histamine. The
medium containing the released VWF was collected after 30 min and the
remaining cells were lysed to determine total VWF levels. The relative
amounts of VWF were quantified by enzyme-linked immunosorbent assay
(ELISA) (Blagoveshchenskaya et al., 2002), and the data were normalised
by using the total VWF signal. The secretagogue-responsive pool was
estimated by subtracting the amount of VWF released by unstimulated
secretion from that released upon secretagogue addition. To combine data
from various independent experiments, data were normalised to the mock
samples in each experiment.
VWF multimer gel
Secreted VWF from unstimulated and 10 μM histamine-stimulated
HUVECs was analysed as described previously (Lui-Roberts et al., 2008).
Briefly, secretion assay samples were loaded onto 1.4% agarose SDS-gels to
separate the multimers, then transferred to a nitrocellulose membrane and
labelled with anti-VWF antibody followed by a HRP-conjugated secondary
antibody.
Cell immunofluorescence and image acquisition
Cells were fixed, prepared as described previously (Lui-Roberts et al., 2005)
and examined at ambient temperature through a 63× oil immersion lens (NA
1.3) on a TCS SP5 confocal microscope system (Leica, Wetzlar, Germany).
Adobe Photoshop 6.0.1, Illustrator CS5 (Adobe Systems, Mountain View,
CA) or ImageJ (Schneider et al., 2012) were used to generate figures from
digital images.
Image processing and parameters used for high-throughput
morphological analysis are described in detail elsewhere (Ferraro et al.,
2014). In brief, images were acquired using an Opera high-content screening
system (Perkin Elmer) by using a 40× air objective (NA 0.6). At least eight
wells per condition were analysed per experiment, with nine images per
well. Maximum Feret diameter (also known as maximum caliper) and
maximum intensity of each VWF-positive object was measured. At least
100,000 VWF-positive structures were analysed per condition. To select the
population of longer WPBs in an unbiased fashion for each control sample
in each individual experiment, VWF-positive objects were sorted by Feret
diameter and the cumulative area was calculated. The top fraction by size of
objects that contained half of the cumulative area were chosen, and the
corresponding Feret diameter of this cut off, typically 2.3–2.4 μm, was used
for all samples within the same experiment. The fraction of VWF-positive
objects with a Feret diameter longer than this cut-off was calculated and
plotted as a proportion of the total population.
In situ and in vivo studies
Pi4k2aGT/GT mice, which lack PI4KIIα kinase activity, were generated
as described previously (Simons et al., 2009). Retinal whole-mounts
from two cohorts of ten animals (five WT littermate controls and five
Pi4k2aGT/GT mice) of 6 months of age were fixed and stained as previously
described (Fruttiger, 2002) with antibodies against VWF and CD31.
Z-stacks of superficial arteries with similar diameters were acquired at
ambient temperature through a 63× oil immersion lens (NA 1.3) on a TCS
SPE confocal microscope system (Leica, Wetzlar, Germany). Analysis of
the maximum intensity of VWF-positive objects was performed on six
maximum-intensity projections (MIPs) from each mouse using ImageJ. In
order to extract the outline of a hemi-vessel, the MIP image was generated
on the endothelial marker (CD31) channel image stack. The VWF channel
was then segmented by using a manually chosen threshold value.
Watershed segmentation was applied in parallel on a copy of the original
MIP image of the VWF channel with a value of 50 as noise tolerance
parameter. The resulted ‘mesh’ image of the watershed-segmented WPB
particles was used to separate the merged WPBs on the other, manually
thresholded, binary MIP image of the VWF channel. WPB Feret diameter,
area, mean grey value and total intensity were selected as features to
measure. WPB objects between area 0.09–8.00 μm2 were measured, the
resulting table was saved in comma-separated file format for further
analysis. For quality control, the region of interest set of all WPB
segmentation outlines was saved and an outline image was generated for
each VWF MIP image in order to validate the precision of the image
analysis workflow.
Tail-bleeding assays were performed by measuring the volume of blood
in a defined period of time (7 min) in a manner similar to that described
previously (Liu et al., 2012), except that the blood was collected at room
temperature directly into a pre-weighed tube and the blood volume
calculated by re-weighing the tube. Animal studies were ethically
reviewed and approved by the UCL Royal Free Campus Ethics and
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Welfare Committee and the UK Home Office, and complied fully with
European Directive 86/609/EEC.
VWF string assay
Nucleofected HUVECs were seeded onto gelatin-coated µ-slides VI0.4
(ibidi, Munich, Germany). Slides were mounted on the microscope stage of
an Axiovert 100 (Carl Zeiss, Welwyn Garden City, UK), maintained at
37°C, and connected to a syringe pump system (Harvard Apparatus,
Holliston, MA) to draw fluid through the chamber with a wall shear stress of
25 Pa (2.5 dyne/cm2). Cells were rinsed with perfusion medium (HBSS
containing Ca2+ and Mg2+, and supplemented with 0.2% BSA) under flow,
to flush through cellular debris and ensure the HUVEC monolayer was
intact. Cells were then perfused with perfusion medium±10 μM histamine
for 5 min followed by perfusion with 4% PFA. Flow speed was gradually
decreased until it stopped completely and cells were left in the presence of
PFA for a total of 20 min, followed by washing and processing for
immunofluorescence without permeabilisation, in order to only stain VWF
on the surface of cells with rabbit anti-VWF antibody and nuclei with DAPI.
Thirty fields of view were taken for each sample at ambient temperature by
using a 20× oil objective on a Leica SP5 confocal scanning microscope
covering an area of 4.5 mm2 (∼500–900 nuclei). The length of each VWF
string was measured manually by using ImageJ.
Statistics
For high-throughput morphometry, all statistical analysis was done using R
(http://www.r-project.org/). Nonparametric, two-tailed, two-independent-
sample Wilcoxon rank-sum test was used to determine statistical
significance of changes in Feret diameter and maximum intensity.
Kullback–Leibler distance was used to estimate the extent of change
between cumulative frequency curves. All other statistical analysis was done
by using GraphPad Prism version 6.0 software, using the tests indicated in
the associated figure legends. Error bars indicate the mean±95% confidence
interval except where indicated otherwise.
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